Literature DB >> 22987110

Pulmonary hypertension in Kawasaki disease.

George T Nicholson1, Cyrus Samai, Usama Kanaan.   

Abstract

This report describes the case of two pediatric patients who demonstrated echocardiographic evidence of pulmonary hypertension (PH) during the acute phase of Kawasaki disease. The etiology of PH development in this setting is currently unknown, but the authors hypothesize that pulmonary vasculitis may play a significant role. Fortunately, the PH appeared to be self-limited and resolved in both cases with routine treatment of Kawasaki disease.

Entities:  

Mesh：

Year:  2012        PMID： 22987110     DOI： 10.1007/s00246-012-0510-6

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN： 0172-0643            Impact factor:   1.655


  8 in total

Review 1.  Pathobiology of pulmonary arterial hypertension and right ventricular failure.

Authors:  Norbert F Voelkel; Jose Gomez-Arroyo; Antonio Abbate; Harm J Bogaard; Mark R Nicolls
Journal:  Eur Respir J       Date:  2012-06-27       Impact factor: 16.671

Review 2.  Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies.

Authors:  Stephen L Archer; E Kenneth Weir; Martin R Wilkins
Journal:  Circulation       Date:  2010-05-11       Impact factor: 29.690

3.  Arterial hemodynamics in patients after Kawasaki disease.

Authors:  Hideaki Senzaki; Chen-Huan Chen; Hirotaka Ishido; Satoshi Masutani; Tamotsu Matsunaga; Mio Taketazu; Toshiki Kobayashi; Nozomu Sasaki; Shunei Kyo; Yuji Yokote
Journal:  Circulation       Date:  2005-04-26       Impact factor: 29.690

4.  Findings in the pulmonary vascular bed in the remote phase after Kawasaki disease.

Authors:  Masaya Sugimoto; Hirotaka Ishido; Mitsuru Seki; Satoshi Masutani; Akiko Tamai; Hideaki Senzaki
Journal:  Am J Cardiol       Date:  2012-01-19       Impact factor: 2.778

5.  Absence of hypercoagulability in acute Kawasaki disease.

Authors:  Ming-Tsan Lin; Lon-Yen Tsao; Ming-Lin Cheng; Yu-Jun Chang; Han-Yao Chiu; Hsiao-Neng Chen; Su-Feng Kuo; Shwu-Jin Chiou
Journal:  Pediatr Int       Date:  2005-04       Impact factor: 1.524

6.  Dobutamine stress radionuclide ventriculography reveals silent myocardial dysfunction in Kawasaki disease.

Authors:  Yuji Hamamichi; Fukiko Ichida; Shinichi Tsubata; Keiichi Hirono; Sayaka Watanabe; Chen Rui; Xianyi Yu; Kei-Ichiro Uese; Ikuo Hashimoto; Masashi Simizu; Hikaru Seto; Hideki Origasa; Toshio Miyawaki
Journal:  Circ J       Date:  2002-01       Impact factor: 2.993

Review 7.  Inflammation and pulmonary hypertension.

Authors:  Rajamma Mathew
Journal:  Cardiol Rev       Date:  2010 Mar-Apr       Impact factor: 2.644

Review 8.  Kawasaki disease.

Authors:  Jane W Newburger; David R Fulton
Journal:  Curr Opin Pediatr       Date:  2004-10       Impact factor: 2.856
  8 in total
  3 in total

1.  Subclinical Pulmonary Hypertension in Childhood Systemic Lupus Erythematosus Associated with Minor Disease Manifestations.

Authors:  Pedro Anuardo; Monica Verdier; Natali W S Gormezano; Gabriela R V Ferreira; Gabriela N Leal; Alessandro Lianza; Juliana C O A Ferreira; Rosa M R Pereira; Nadia E Aikawa; Maria Teresa Terreri; Claudia S Magalhães; Simone Appenzeller; Maria Carolina Dos Santos; Silvana B Sachetti; Claudio A Len; Gecilmara S Pilleggi; Simone Lotufo; Eloisa Bonfá; Clovis A Silva
Journal:  Pediatr Cardiol       Date:  2016-11-08       Impact factor: 1.655

2.  Pulmonary Artery Dilation and Right Ventricular Function in Acute Kawasaki Disease.

Authors:  Fujito Numano; Chisato Shimizu; Adriana H Tremoulet; Dan Dyar; Jane C Burns; Beth F Printz
Journal:  Pediatr Cardiol       Date:  2015-12-17       Impact factor: 1.838

3.  Lipocalin-2-induced proliferative endoplasmic reticulum stress participates in Kawasaki disease-related pulmonary arterial abnormalities.

Authors:  Zhaoling Shi; Yue Yin; Chen Li; Hui Ding; Nan Mu; Yishi Wang; Shanshan Jin; Heng Ma; Manling Liu; Jie Zhou
Journal:  Sci China Life Sci       Date:  2020-09-09       Impact factor: 6.038
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.